Schechter Lori A.
Known title: EVP, Chief Legal Officer & GCCIK: 0001612098
Associated companies
Transaction History
| MCK | ▼ Sell | Open Market | 11,195 | $4.2M | 5/31/2023 | View on chart |
| MCK | ▼ Sell | Open Market | 2,542 | $976K | 5/30/2023 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 903 | $350K | 5/26/2023 | View on chart |
| MCK | ▼ Sell | Open Market | 640 | $252K | 5/26/2023 | View on chart |
| MCK | ▲ Buy | Option Exercise | 2,329 | $0 | 5/26/2023 | View on chart |
| MCK | ▲ Buy | Option Exercise | 1,772 | $0 | 5/25/2023 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 656 | $259K | 5/25/2023 | View on chart |
| MCK | ▲ Buy | Option Exercise | 1,056 | $0 | 5/24/2023 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 416 | $165K | 5/24/2023 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 5,919 | $2.3M | 5/23/2023 | View on chart |
| MCK | ▲ Buy | Grant | 17,114 | $0 | 5/23/2023 | View on chart |
| MCK | ▼ Sell | Open Market | 2,500 | $949K | 12/9/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 2,500 | $978K | 11/10/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 2,500 | $868K | 10/10/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 7,500 | $2.6M | 9/15/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 5,488 | $793K | 5/31/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 5,488 | $1.8M | 5/31/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 1,350 | $451K | 5/27/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 24,169 | $8.0M | 5/26/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 2,328 | $0 | 5/26/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 978 | $329K | 5/26/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 1,772 | $0 | 5/25/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 17,105 | $0 | 5/25/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 6,731 | $2.2M | 5/25/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 698 | $233K | 5/25/2022 | View on chart |
| MCK | ▲ Buy | Grant | 22,140 | $0 | 5/24/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 9,419 | $3.1M | 5/24/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 1,500 | $490K | 5/24/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 2,707 | $0 | 5/21/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 1,207 | $390K | 5/21/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 15,842 | $3.8M | 12/29/2021 | View on chart |
| MCK | ▼ Sell | Open Market | 15,842 | $4.0M | 12/29/2021 | View on chart |
| MCK | ▼ Sell | Open Market | 10,249 | $2.3M | 11/10/2021 | View on chart |
| MCK | ▲ Buy | Option Exercise | 19,112 | $0 | 11/9/2021 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 8,863 | $1.9M | 11/9/2021 | View on chart |
| MCK | ▲ Buy | Option Exercise | 5,488 | $793K | 11/3/2021 | View on chart |
| MCK | ▼ Sell | Open Market | 5,488 | $1.2M | 11/3/2021 | View on chart |
| MCK | ▲ Buy | Option Exercise | 27,720 | $5.1M | 11/2/2021 | View on chart |
| MCK | ▼ Sell | Open Market | 27,720 | $6.0M | 11/2/2021 | View on chart |
| MCK | ▼ Sell | Open Market | 21,204 | $4.7M | 11/2/2021 | View on chart |
| MCK | ▲ Buy | Option Exercise | 21,204 | $3.4M | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
McKesson Re-Rated on M&A Momentum Amid Strong Performance
McKesson shares have risen while the broader market fell, driven by renewed analyst interest in the company's increased M&A efforts. This positive sentiment aligns with recent recognition from financial commentators who view the healthcare stock as a strong performer. The stock's strength is further supported by a high RSI, indicating significant recent buying pressure.
McKesson Re-Rated on M&A Momentum Amid Strong Performance. McKesson shares have risen while the broader market fell, driven by renewed analyst interest in the company's increased M&A efforts. This positive sentiment aligns with recent recognition from financial commentators who view the healthcare stock as a strong performer. The stock's strength is further supported by a high RSI, indicating significant recent buying pressure.